Liminal BioSciences Inc.: Liminal BioSciences Regains Compliance with NASDAQ Minimum Bid Price Requirement
LAVAL, QC, Feb. 15, 2023 /PRNewswire/ -- Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), announced that it has received written notice from The Nasdaq Stock